Skip to main content

Amundi

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1330387 Paris, I0

Position in REGN

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$780,210,323
+$168,961,841 QoQ
Shares Held
1,009,798
+27.5% QoQ
Ownership
0.963%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Amundi holds $2,277,505,863 across 70 Biotechnology names. REGN ranks #1 (34.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
1,009,798 $780,210,323

All Filings in REGN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $780,210,323 1,009,798
2025-12-31 $611,248,482 791,906
2025-09-30 $349,586,310 621,741
2025-06-30 $470,993,775 897,131
2025-03-31 $1,017,242,120 1,603,901
2024-12-31 $1,105,347,380 1,551,735
2024-09-30 $1,118,777,952 1,064,246
2024-06-30 $1,118,630,137 1,064,318
2024-03-31 $1,016,831,212 1,056,459
2023-12-31 $802,866,837 914,125
2023-09-30 $563,962,957 685,286
2023-06-30 $491,992,950 684,712
2023-03-31 $634,505,889 772,215
2022-12-31 $501,749,390 695,435
2022-09-30 $451,340,730 655,190
2022-06-30 $327,786,304 554,508
2022-03-31 $348,462,683 498,930
2021-12-31 $290,707,594 460,330
2021-09-30 $258,083,244 426,457
2021-06-30 $112,500,560 201,419